{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:33:05Z","timestamp":1788571985960,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00467-018-4112-2","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T12:30:48Z","timestamp":1540470648000},"page":"517-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement"],"prefix":"10.1007","volume":"34","author":[{"given":"Paolo","family":"Giordano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Stefano","family":"Netti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta Domenica","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marida","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Sesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Di Cuonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Resta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Milella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chironna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Germinario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Scavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-636X","authenticated-orcid":false,"given":"Mario","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"4112_CR1","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00467-007-0616-x","volume":"23","author":"L Copelovitch","year":"2008","unstructured":"Copelovitch L, Kaplan BS (2008) The thrombotic microangiopathies. Pediatr Nephrol 23:1761\u20131767","journal-title":"Pediatr Nephrol"},{"key":"4112_CR2","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","volume":"27","author":"JT Kielstein","year":"2012","unstructured":"Kielstein JT, Beutel G, Fleig S, Steinhoff J, Meyer TN, Hafer C, Kuhlmann U, Bramstedt J, Panzer U, Vischedyk M, Busch V, Ries W, Mitzner S, Mees S, Stracke S, N\u00fcrnberger J, Gerke P, Wiesner M, Sucke B, Abu-Tair M, Kribben A, Klause N, Schindler R, Merkel F, Schnatter S, Dorresteijn EM, Samuelsson O, Brunkhorst R, Collaborators of the DGfN STEC-HUS registry (2012) Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga toxin-producing E. coli O104:H4 induced haemolytic\u2013uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 27:3807\u20131385","journal-title":"Nephrol Dial Transplant"},{"key":"4112_CR3","doi-asserted-by":"publisher","unstructured":"Ardissino G, Tel F, Possenti I, Testa S, Consonni D, Paglialonga F, Salardi S, Borsa-Ghiringhelli N, Salice P, Tedeschi S, Castorina P, Colombo RM, Arghittu M, Daprai L, Monzani A, Tozzoli R, Brigotti M, Torresani E (2016) Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2015-2153","DOI":"10.1542\/peds.2015-2153"},{"key":"4112_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archpediatrics.2011.152","volume":"165","author":"CA Hickey","year":"2011","unstructured":"Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL, Patel HP, Wong CS, Andreoli SP, Rothbaum RJ, Beck AM, Tarr PI (2011) Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 165:884\u2013889","journal-title":"Arch Pediatr Adolesc Med"},{"key":"4112_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/978-3-540-76341-3_48","volume-title":"Pediatric nephrology","author":"S Johnson","year":"2009","unstructured":"Johnson S, Taylor CM (2009) Hemolytic uremic syndrome, cap. 48. In: Pediatric nephrology, 6th edn. Springer Verlag, Berlin Heidelberg, pp 1155\u20131178","edition":"6"},{"key":"4112_CR6","doi-asserted-by":"crossref","unstructured":"Corogeanu D, Willmes R, Wolke M, Plum G, Uterm\u00f6hlen O, Kr\u00f6nke M. (2012) Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak. BMC Microbiol 12:160","DOI":"10.1186\/1471-2180-12-160"},{"key":"4112_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/cid\/ciw099","volume":"62","author":"SB Freedman","year":"2015","unstructured":"Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr P, Alberta Provincial Pediatric Enteric Infection Team (APPETITE), Nettel-Aguirre A, Chuck A, Lee B, Johnson D, Currie G, Talbot J, Jiang J, Dickinson J, Kellner J, MacDonald J, Svenson L, Chui L, Louie M, Lavoie M, Eltorki M, Vanderkooi O, Tellier R, Ali S, Drews S, Graham T, Pang XL, (Alberta Provincial Pediatric Enteric Infection Team,APPETITE) (2015) Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis. Clin Infect Dis 62:1251\u20131258","journal-title":"Clin Infect Dis"},{"key":"4112_CR8","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.tiv.2015.06.025","volume":"29","author":"N Angel Villegas","year":"2015","unstructured":"Angel Villegas N, Baronetti J, Albesa I, Etcheverr\u00eda A, Becerra MC, Padola NL, Paraje MG (2015) Effect of antibioticsoncellular stress generated in Shigatoxin-producing Escherichia coli O157:H7 and non-O157 biofilms. Toxicol in Vitro 29:1692\u20131700","journal-title":"Toxicol in Vitro"},{"key":"4112_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijantimicag.2015.08.006","volume":"46","author":"H Tajiri","year":"2015","unstructured":"Tajiri H, Nishi J, Ushijima K, Shimizu T, Ishige T, Shimizu M, Tanaka H, Brooks S (2015) A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. Int J Antimicrob Agents 46:586\u2013589","journal-title":"Int J Antimicrob Agents"},{"key":"4112_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0022-3476(88)80071-4","volume":"112","author":"G Rizzoni","year":"1998","unstructured":"Rizzoni G, Claris-Appiani A, Edefonti A, Facchin P, Franchini F, Gusmano R, Imbasciati E, Pavanello L, Perfumo F, Remuzzi G (1998) Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr 112:284\u2013290","journal-title":"J Pediatr"},{"key":"4112_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1525-1594.1995.tb02370.x","volume":"19","author":"J Slavicek","year":"1995","unstructured":"Slavicek J, Pureti\u0107 Z, Novak M, Sarnavka V, Benjak V, Glavas-Boras S, Thune S (1995) The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood. Artif Organs 19:506\u2013510","journal-title":"Artif Organs"},{"key":"4112_CR12","first-page":"S125","volume":"54","author":"A Tummolo","year":"2012","unstructured":"Tummolo A, Colella V, Bellantuono R, Giordano M, Messina G, Puteo F, Sorino P, De Palo T (2012) [Apheresis in children: procedures and outcome.] G Ital. Nefrol Suppl 54:S125\u2013S129","journal-title":"Nefrol Suppl"},{"key":"4112_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","volume":"378","author":"E Colic","year":"2011","unstructured":"Colic E, Dieperink H, Titlestad K, Tepel M (2011) Management of an acute outbreak of diarrhoea-associated haemolyticuraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 378:1089\u20131093","journal-title":"Lancet"},{"key":"4112_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1055\/s-0030-1262881","volume":"36","author":"M Bitzan","year":"2010","unstructured":"Bitzan M, Schaefer F, Reymond D (2010) Treatment of typical (enteropathic) hemolytic uremic syndrome. Semin Thromb Hemost 36:594\u2013610","journal-title":"Semin Thromb Hemost"},{"key":"4112_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","volume":"53","author":"M Michael","year":"2009","unstructured":"Michael M, Elliott EJ, Craig JC, Ridley G, Hodson EM (2009) Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis 53:259\u2013272","journal-title":"Am J Kidney Dis"},{"key":"4112_CR16","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749\u20131760","journal-title":"Pediatr Nephrol"},{"key":"4112_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0042-108444","volume":"228","author":"J Matthies","year":"2016","unstructured":"Matthies J, H\u00fcnseler C, Ehren R, Volland R, K\u00f6rber F, Hoppe B, Weber LT, Habbig S (2016) Extrarenal manifestations in Shiga toxin-associated haemolytic uremic syndrome. Klin Paediatr 228:181\u2013188","journal-title":"Klin Paediatr"},{"key":"4112_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrneph.2012.196","volume":"8","author":"H Trachtman","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 8:658\u2013669","journal-title":"Nat Rev Nephrol"},{"key":"4112_CR19","first-page":"1","volume":"97","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T (2014) Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr 97:1\u201316","journal-title":"Front Pediatr"},{"key":"4112_CR20","doi-asserted-by":"crossref","unstructured":"Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C, Christen E, Trachtman H (2009) Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol. 41920\u20131924","DOI":"10.2215\/CJN.02730409"},{"key":"4112_CR21","doi-asserted-by":"crossref","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, Proulx F, Clermont MJ, Le Deist F, Niaudet P (2011)Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364:2561\u20132563","DOI":"10.1056\/NEJMc1100859"},{"key":"4112_CR22","doi-asserted-by":"publisher","first-page":"30343","DOI":"10.2807\/1560-7917.ES.2016.21.38.30343","volume":"21","author":"C Germinario","year":"2016","unstructured":"Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS, Tafuri S, Minelli F, Maugliani A, Michelacci V, Santangelo L, Mongelli O, Montagna C, Scavia G, all participants of the Outbreak investigation team (2016) Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Euro Surveill 21:30343","journal-title":"Euro Surveill"},{"key":"4112_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1473-3099(11)70165-7","volume":"11","author":"M Bielaszewska","year":"2011","unstructured":"Bielaszewska M, Mellmann A, Zhang W, K\u00f6ck R, Fruth A, Bauwens A, Peters G, Karch H (2011) Characterisation of the Escherichia coli strain associated with an outbreak of haemolyticuraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11:671\u2013676","journal-title":"Lancet Infect Dis"},{"key":"4112_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Pi\u00e8trement C, Champion G, Ulinski T, Desch\u00eanes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218\u20131228","journal-title":"Clin J Am Soc Nephrol"},{"key":"4112_CR25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/dmcn.12161","volume":"55","author":"C Gitiaux","year":"2013","unstructured":"Gitiaux C, Krug P, Grevent D, Kossorotoff M, Poncet S, Eisermann M, Oualha M, Boddaert N, Salomon R, Desguerre I (2013) Brain magnetic resonance imaging pattern and outcome in children with haemolytic-uraemic syndrome and neurological impairment treated with eculizumab. Dev Med Child Neurol 55:758\u2013765","journal-title":"Dev Med Child Neurol"},{"key":"4112_CR26","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s001150050066","volume":"67","author":"D Ohlmann","year":"1996","unstructured":"Ohlmann D, Hamann GF, Hassler M, Schimrigk K (1996) Involvement of the central nervous system in hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura. Nervenarzt 67:880\u2013882","journal-title":"Nervenarzt"},{"key":"4112_CR27","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/brain\/aws090","volume":"135","author":"T Magnus","year":"2012","unstructured":"Magnus T, R\u00f6ther J, Simova O, Meier-Cillien M, Repenthin J, M\u00f6ller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135:1850\u20131859","journal-title":"Brain"},{"key":"4112_CR28","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1128\/IAI.64.12.5053-5060.1996","volume":"64","author":"J Fujii","year":"1996","unstructured":"Fujii J, Kinoshita Y, Kita T, Higure A, Takeda T, Tanaka N, Yoshida S (1996) Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun 64:5053\u20135060","journal-title":"Infect Immun"},{"key":"4112_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2008.02.012","volume":"196","author":"M Shiraishi","year":"2008","unstructured":"Shiraishi M, Ichiyama T, Matsushige T, Iwaki T, Iyoda K, Fukuda K, Makata H, Matsubara T, Furukawa S (2008) Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy. J Neuroimmunol 196:147\u2013152","journal-title":"J Neuroimmunol"},{"key":"4112_CR30","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1128\/IAI.69.3.1889-1894.2001","volume":"69","author":"PB Eisenhauer","year":"2001","unstructured":"Eisenhauer PB, Chaturvedi P, Fine RE, Ritchie AJ, Pober JS, Cleary TG, Newburg DS (2001) Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin. Infect Immun 69:1889\u20131894","journal-title":"Infect Immun"},{"key":"4112_CR31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00467-002-1025-9","volume":"18","author":"Z Ergonul","year":"2003","unstructured":"Ergonul Z, Clayton F, Fogo AB, Kohan DE (2003) Shigatoxin-1 binding and receptorexpression in human kidneys do not change with age. Pediatr Nephrol 18:246\u2013253","journal-title":"Pediatr Nephrol"},{"key":"4112_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamapediatrics.2016.2952","volume":"171","author":"S Grisaru","year":"2017","unstructured":"Grisaru S, Xie J, Samuel S, Hartling L, Tarr PI, Schnadower D, Freedman SB, Alberta Provincial Pediatric Enteric Infection Team (2017) Associations between hydration status, intravenous fluid administration, and outcomes of patients infected with Shiga toxin-producing Escherichia coli: a systematic review and meta-analysis. JAMA Pediatr 171:68\u201376","journal-title":"JAMA Pediatr"},{"key":"4112_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-2094-5-11","volume":"5","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5:11","journal-title":"J Neuroinflammation"},{"key":"4112_CR34","doi-asserted-by":"crossref","unstructured":"Arieff AI, Llach F, Massry SG (1976) Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes Medicine 55:12112\u201312119","DOI":"10.1097\/00005792-197603000-00002"},{"key":"4112_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3345\/kjp.2013.56.12.519","volume":"56","author":"SJ Park","year":"2013","unstructured":"Park SJ, Shin JI (2013) Inflammation and hyponatremia: an under recognized condition? Korean J Pediatr 56:519\u2013522","journal-title":"Korean J Pediatr"},{"key":"4112_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1442-200X.2008.02672.x","volume":"51","author":"T Teramoto","year":"2009","unstructured":"Teramoto T, Fukao T, Hirayama K, Asano T, Aoki Y, Kondo N (2009) Escherichia coli O-157-induced hemolytic uremic syndrome: usefulness of SCWP score for the prediction of neurological complication. Pediatr Int 51:107\u2013109","journal-title":"Pediatr Int"},{"key":"4112_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cid\/cis533","volume":"55","author":"PI Tarr","year":"2012","unstructured":"Tarr PI, Karpmann D (2012) Editorial commentary: Escherichia coli O104:H4 and hemolytic uremic syndrome: the analysis begins. Clinl Infect Dis 55:760\u2013763","journal-title":"Clinl Infect Dis"},{"key":"4112_CR38","doi-asserted-by":"crossref","unstructured":"Orth-H\u00f6ller D, W\u00fcrzner R (2014) Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome (2014) Semin Thromb Hemost 40(4):503\u2013507","DOI":"10.1055\/s-0034-1375295"},{"key":"4112_CR39","doi-asserted-by":"crossref","unstructured":"Hillmen P, Muus P, R\u00f6th A, Eletube MO, Risitano M, Schrezenmeier H, Szer J, Browne P, Maciejewski JP, Schubert J, Urbano-Ispizua A, de Castro C, Soci\u00e9 G, Brodsky RA (2013) Long term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 162:62\u201373","DOI":"10.1111\/bjh.12347"},{"key":"4112_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ndt\/gft470","volume":"29","author":"Y Delmas","year":"2014","unstructured":"Delmas Y, Vendrely B, Clouzeau B, Bachir H, Bui HN, Lacraz A, H\u00e9lou S, Bordes C, Reffet A, Llanas B, Skopinski S, Rolland P, Gruson D, Combe C (2014) Outbreak of Escherichia coli O104:H4 haemolyticuraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant 29:565\u2013572","journal-title":"Nephrol Dial Transplant"},{"key":"4112_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1055\/s-0034-1375295","volume":"40","author":"R W\u00fcrzner","year":"2014","unstructured":"W\u00fcrzner R, Riedl M, Rosales A, Orth-H\u00f6ller D (2014) Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS). Semin Thromb Hemost 40:508\u2013516","journal-title":"Semin Thromb Hemost"},{"key":"4112_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/cid\/cis531","volume":"55","author":"S Loos","year":"2012","unstructured":"Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, H\u00e4rtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, M\u00fcller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, K\u00f6nig J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ (2012) An outbreak of Shigatoxin producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55:753\u2013759","journal-title":"Clin Infect Dis"},{"key":"4112_CR43","unstructured":"Luzzi I, Garc\u00eda-Fern\u00e1ndez A, Dionisi AM, Lucarelli C, Gattuso A, Gianfranceschi M, Maugliani A, Caprioli A, Morabito S, Scavia G (2017). Enter-Net Italia and the Italian registry of hemolytic uremic syndrome: surveillance of Salmonella, Campylobacter, Shiga-toxin producer Escherichia coli and Listeria monocytogenes infections (2010-2015). Reports of Italian Institute of Health (Rapporti ISTISAN) 17\/34, ii, 70 p. (in Italian)"},{"key":"4112_CR44","doi-asserted-by":"crossref","unstructured":"Ardissino G, Dacc\u00f2 V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F; ItalKid Project (2003) Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 111(4 Pt 1):e382\u2013e387","DOI":"10.1542\/peds.111.4.e382"},{"key":"4112_CR45","unstructured":"Krug P., Oualha M., Boyer O. Gitiaux C., Grevent D., Boddaert N., Niaudet P., Salomon R. \u201cNeurological involvement in E. coli-associated Hemolytic Uremic Syndrome\u201d, 9th May 2012, Amsterdam,8th international symposium on Shiga toxin producing E. coli Infections"},{"key":"4112_CR46","first-page":"230","volume":"26","author":"DM Ward","year":"2011","unstructured":"Ward DM (2011) Conventional apheresis therapies: a review. J ClinApher 26:230\u2013238","journal-title":"J ClinApher"},{"key":"4112_CR47","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0140-6736(11)61253-1","volume":"378","author":"A Greinacher","year":"2011","unstructured":"Greinacher A, Friesecke S, Abel P, Dressel A, Stracke S, Fiene M, Ernst F, Selleng K, Weissenborn K, Schmidt BM, Schiffer M, Felix SB, Lerch MM, Kielstein JT, Mayerle J (2011) Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4- associated haemolyticuraemic syndrome: a prospective trial. Lancet 378:1166\u20131173","journal-title":"Lancet"},{"key":"4112_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40620-016-0294-5","volume":"29","author":"B Flam","year":"2016","unstructured":"Flam B, Sackey P, Berge A, Zachau AC, Brink B, Lundberg S (2016) Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption. J Nephrol 29:711\u2013714","journal-title":"J Nephrol"},{"key":"4112_CR49","doi-asserted-by":"crossref","unstructured":"Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (2015) Eculizumab in typical hemolytic uremic syndrome HUS) with neurological involvement. Medicine 94:e1000","DOI":"10.1097\/MD.0000000000001000"},{"key":"4112_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0009922814534520","volume":"54","author":"A Saini","year":"2015","unstructured":"Saini A, Emke AR, Silva MC, Perlman SJ (2015) Response to eculizumab in Escherichia Coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations. Clin Pediatr 54:387\u2013389","journal-title":"Clin Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4112-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4112-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T19:25:40Z","timestamp":1720725940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4112-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4112"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4112-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,25]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We carried out a retrospective study based on registry data and no ethics approval was required. Nevertheless, all the children\u2019s parents signed a written informed consent to collect their clinical data at time of hospital access.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}